Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis
- PMID: 38842034
- PMCID: PMC11499046
- DOI: 10.1002/ohn.835
Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysis
Abstract
Objective: Initiating postoperative radiotherapy (PORT) within 6 weeks of surgery for head and neck squamous cell carcinoma (HNSCC) is included in the National Comprehensive Cancer Network Clincal Practice Guidelines and is a Commission on Cancer quality metric. Factors associated with delays in starting PORT have not been systematically described nor synthesized.
Data sources: PubMed, Scopus, and CINAHL.
Review methods: We included studies describing demographic characteristics, clinical factors, or social determinants of health associated with PORT delay (>6 weeks) in patients with HNSCC treated in the United States after 2003. Meta-analysis of odds ratios (ORs) was performed on nonoverlapping datasets.
Results: Of 716 unique abstracts reviewed, 21 studies were included in the systematic review and 15 in the meta-analysis. Study sample size ranged from 19 to 60,776 patients. In the meta-analysis, factors associated with PORT delay included black race (OR, 1.46, 95% confidence interval [CI]: 1.28-1.67), Hispanic ethnicity (OR, 1.37, 95% CI, 1.17-1.60), Medicaid or no health insurance (OR, 2.01, 95% CI, 1.90-2.13), lower income (OR, 1.38, 95% CI, 1.20-1.59), postoperative admission >7 days (OR, 2.92, 95% CI, 2.31-3.67), and 30-day hospital readmission (OR, 1.37, 95% CI, 1.29-1.47).
Conclusion: Patients at greatest risk for a delay in initiating guideline-adherent PORT include those who are from minoritized communities, of lower socioeconomic status, and experience postoperative challenges. These findings provide the foundational evidence needed to deliver targeted interventions to enhance equity and quality in HNSCC care delivery.
Keywords: Commission on Cancer; National Comprehensive Cancer Network; adjuvant therapy; head and neck cancer; health equity; quality; radiotherapy; social determinants of health.
© 2024 American Academy of Otolaryngology–Head and Neck Surgery Foundation.
Conflict of interest statement
Similar articles
-
Delays Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients: A Systematic Review and Meta-analysis.Otolaryngol Head Neck Surg. 2024 Feb;170(2):320-334. doi: 10.1002/ohn.538. Epub 2023 Sep 20. Otolaryngol Head Neck Surg. 2024. PMID: 37731255 Free PMC article.
-
Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.Cancer. 2017 Jul 15;123(14):2651-2660. doi: 10.1002/cncr.30651. Epub 2017 Feb 27. Cancer. 2017. PMID: 28241092
-
Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg. 2024 Jun 1;150(6):472-482. doi: 10.1001/jamaoto.2024.0424. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38662392 Free PMC article.
-
Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):455-464. doi: 10.1001/jamaoto.2020.0222. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32239201 Free PMC article.
-
An equity-based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma.Laryngoscope Investig Otolaryngol. 2021 Nov 9;6(6):1358-1366. doi: 10.1002/lio2.692. eCollection 2021 Dec. Laryngoscope Investig Otolaryngol. 2021. PMID: 34938875 Free PMC article. Review.
Cited by
-
Optimal timing of cancer treatments: a call for emerging evidence from clinical trials and real-world studies.Br J Cancer. 2025 Jun;132(12):1085-1090. doi: 10.1038/s41416-025-03030-4. Epub 2025 Apr 23. Br J Cancer. 2025. PMID: 40269312 Free PMC article. Review.
-
Factors Contributing to Postoperative Radiotherapy Delays in Head and Neck Cancer: A Comprehensive Review.Cureus. 2024 Aug 19;16(8):e67240. doi: 10.7759/cureus.67240. eCollection 2024 Aug. Cureus. 2024. PMID: 39301336 Free PMC article. Review.
-
Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck Cancer.JCO Oncol Pract. 2025 Aug;21(8):1153-1164. doi: 10.1200/OP-24-00901. Epub 2025 Jan 6. JCO Oncol Pract. 2025. PMID: 39761486
-
MYO1B promotes radioresistance in head and neck squamous cell carcinoma by regulating tumor stemness and DNA damage repair via the PI3K/AKT pathway.Cancer Cell Int. 2025 Jul 2;25(1):248. doi: 10.1186/s12935-025-03863-2. Cancer Cell Int. 2025. PMID: 40604770 Free PMC article.
-
Disparities in Survival of Head and Neck Cancer in the Hispanic Population: Systematic-Review and Meta-analysis.Otolaryngol Head Neck Surg. 2025 Apr;172(4):1177-1191. doi: 10.1002/ohn.1113. Epub 2025 Jan 5. Otolaryngol Head Neck Surg. 2025. PMID: 39756015
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical